Meeting report: The 2009 westlake international conference on personalized medicine

OMICS A Journal of Integrative Biology

Volumn 13, Issue 4, 2009, Pages 285-289

  Lin, Biaoyang ^a   Strickland, Susy J ^a   Wang, Jun ^a   Qi, Lifeng ^a   Kolker, Eugene ^b   Nam, Hong Gil ^c   Li, Lanjuan ^d   Gu, Jianren ^e  

^a ZHEJIANG UNIVERSITY   (China)

^b UNIVERSITY OF WASHINGTON   (United States)

^c Pohang University of Science and Technology (POSTECH)   (South Korea)

^d ZHEJIANG UNIVERSITY   (China)

^e SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARTIFICIAL LIVER; CANCER THERAPY; CLINICAL TRIAL; CONFERENCE PAPER; EPIGENETICS; HUMAN; MEDICINE; MULTICENTER STUDY; NANOTECHNOLOGY; PHARMACOGENOMICS; PREVENTIVE MEDICINE; PRIORITY JOURNAL; PROTEOMICS;

CONGRESSES AS TOPIC; GENOMICS; HUMANS; INTERNATIONAL COOPERATION; NANOTECHNOLOGY; NEOPLASMS; PHARMACOGENETICS; PROTEOMICS; SOCIETIES, MEDICAL; SYSTEMS BIOLOGY;

EID: 69249152632     PISSN: 15362310     EISSN: None     Source Type: Journal    
DOI: 10.1089/omi.2009.0MRe     Document Type: Conference Paper

References (10)

1. Eisterer, W., Jiang, X., Bachelot, T., Pawliuk, R., Abramovich, C., Leboulch, P., et al. (2002). Unfulfilled promise of endostatin in a gene therapy-xenotransplant model of human acute lymphocytic leukemia. Mol Ther 5, 352-359.
2. Fais, S., De Milito, A., You, H., and Qin, W. (2007). Targeting vacuolar H+-ATPases as a new strategy against cancer. Cancer Res 67, 10627-10630.
3. Galas, D.J., and Hood, L. (2009). Systems biology and emerging technologies will catalyze the transition from reactive medicine to predictive, personalized, preventive and participatory (p4) medicine. Interdispl Bio Central 1, 1-4.
4. Holcomb, I.N., Grove, D.I., Kinnunen, M., Friedman, C.L., Gallaher, I.S., Morgan, T.M., et al. (2008). Genomic alterations indicate tumor origin and varied metastatic potential of disseminated cells from prostate cancer patients. Cancer Res 68, 5599-5608.
5. Hood, L., Heath, J.R., Phelps, M.E., and Lin, B. (2004). Systems biology and new technologies enable predictive and preventative medicine. Science 306, 640-643.
6. Hwang, D., Lee, I.Y., Yoo, H., Gehlenborg, N., Cho, J.H., Petritis, B., et al. (2009). A systems approach to prion disease. Mol Syst Biol 5, 252.
7. Jain, K.K. (2008). Handbook of Nanomedicine. (Humana=Springer, Totowa, NJ).
8. Jain, K.K. (2009). Textbook of Personalized Medicine. (Springer, New York).
9. Lin, B., White, J.T., Lu, W., Xie, T., Utlega, G., Yan, X., et al. (2005). Evidence for the presence of disease-perturbed networks in prostate cancer cells by genomic and proteomic analyses: a systems approach to disease. Cancer Res 65, 3081-3091.
10. Qi, L., and Gao, X. (2008). Quantum dot-amphipol nanocomplex for intracellular delivery and real-time imaging of siRNA. ACS Nano 2, 1403-1410.